The purpose of this study is to compare the number of responders to vaccination with the influenza virus vaccine at different time points after last dose of rituximab in patients with lymphoma. Secondly to study the immune-response to vaccination with influenza virus vaccine, after treatment with rituximab in relation to the reconstitution of immune-function.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
98
Canisius Wilhelmina Hospital
Nijmegen, Gelderland, Netherlands
Onze Lieve Vrouwen Gasthuis
Amsterdam, North Holland, Netherlands
Medisch Spectrum Twente
Enschede, Overrijssel, Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, Provincie Friesland, Netherlands
Influenza antibody titre
Time frame: 3 weeks after vaccination
number of memory B cells
Time frame: 6 months
lymphocyte subsets
Time frame: 6 months
immunoglobulin levels
Time frame: 6 months
IgG subclasses
Time frame: 6 months
production of IFN-γ by CD4+ cells
Time frame: 6 months
Cytokines
Time frame: 6 months
genetic factors
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Reinier de Graaf Groep
Delft, South Holland, Netherlands
Albert Schweitzer Hospital
Dordrecht, South Holland, Netherlands
St. Antonius Hospital
Nieuwegein, Utrecht, Netherlands